We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current FENC market cap is 242.55M. The company's latest EPS is USD -0.0158 and P/E is -754.43.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 25.38M | 7.26M | 6.97M | 7.93M | 8.75M |
| Operating Income | 13.74M | -5.04M | -5.2M | -934k | -808k |
| Net Income | 12.84M | -5.55M | -5.74M | -1.99M | -1.17M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 170k | 0 | 1.54M | 21.25M | 47.54M |
| Operating Income | -17.89M | -17.22M | -22.74M | -12.77M | 2.57M |
| Net Income | -18.11M | -17.35M | -23.71M | -16.05M | -436k |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 69.19M | 63.16M | 58.92M | 44.95M | 46.4M |
| Total Liabilities | 66.18M | 64.52M | 64.09M | 50.82M | 52.28M |
| Total Equity | 3.01M | -1.36M | -5.17M | -5.87M | -5.88M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 31.42M | 22.41M | 26.94M | 26.86M | 44.95M |
| Total Liabilities | 2.35M | 6.64M | 29.51M | 38.49M | 50.82M |
| Total Equity | 29.07M | 15.77M | -2.57M | -11.62M | -5.87M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 39.05M | 30.66M | 28.45M | 26.98M | -4.32M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -1.13M | -875k | -1.4M | -13.62M | 359k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.6M | -14.22M | -18.06M | -17.14M | 26.98M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 32.29M | 4.98M | 20.73M | 6.64M | -13.62M |
| Market Cap | 242.55M |
| Price to Earnings Ratio | -754.43 |
| Price to Sales Ratio | 6.92 |
| Price to Cash Ratio | 12.35 |
| Price to Book Ratio | -56.02 |
| Dividend Yield | - |
| Shares Outstanding | 27.59M |
| Average Volume (1 week) | 76.65k |
| Average Volume (1 Month) | 80.93k |
| 52 Week Change | 34.61% |
| 52 Week High | 9.30 |
| 52 Week Low | 3.96 |
| Spread (Intraday) | 1.27 (12.96%) |
| Company Name | Fennec Pharmaceuticals Inc |
| Address |
c/o labarge weinstein llp ottawa, ontario K2K 3G4 |
| Website | https://www.fennecpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
